🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase III study will evaluate the efficacy, safety and pharmacokinetic...
Status
Terminated
Location
University of Alabama at Birmingham
Start Date
2021-03-19
Trial ID
NCT04552899
Treatments Being Tested
This study will assess the safety and tolerability of PRM-151 administered ...
Status
Completed
Location
University Hospital Leuven
Start Date
2010-06-14
Trial ID
NCT01064817
This study will evaulate the long-term safety, efficacy and pharmacokinetic...
Status
Terminated
Location
University of Alabama at Birmingham
Start Date
2021-08-30
Trial ID
NCT04594707
Treatments Being Tested
The aims of the study are to assess safety, tolerability, the pharmacokinet...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2011-03-29
Trial ID
NCT01254409
This study is a Phase 2, randomized, double-blind, placebo controlled, pilo...
Status
Completed
Location
UCSF Interstitial Lung Disease Program
Start Date
2015-09-01
Trial ID
NCT02550873
RO7490677 is an investigational drug that is being developed for possible u...
Status
Completed
Location
Mayo Clinic Cancer Center
Start Date
2013-10-01
Trial ID
NCT01981850
Treatments Being Tested